Skip to main content

36-page impact report highlights how faculty, staff, and students at the University of North Carolina at Chapel Hill take ideas to market and innovations to scale.

This report highlights the evolving focus of Innovate Carolina over fiscal years 2021 and 2022 in how it makes an economic and human impact in North Carolina and globally. The report includes stats, program briefs, and stories about how Innovate Carolina works with faculty, students, and the community to make a positive difference through technology commercialization, venture creation, and innovation in practice.

diverse scientist in lab setting - Inside one of the labs at AskBio, a UNC-affiliated gene therapy company that was acquired by Bayer in a deal worth up to $4 billion in late 2020.

A few highlights

on page 5:

  • UNC Inventions include therapeutics, research tools/methods, biomarkers/diagnostics, drug delivery, imaging, and much more.
  • Congruent with Carolina’s research pipeline that is focused heavily on biomedical endeavors, the majority of its licenses are in the life sciences sector.
  • 36 % of licenses were related to tangible property (research tools, including mice, cell lines, and antibodies).

on page 16:

design rendering new innovation district coming in Spring 2023 - Design rendering of the University’s new innovation hub at 136 E. Rosemary and 137 E. Franklin Streets. The hub will open in spring 2023 and be home to Innovate Carolina and its services for the entrepreneurial community on campus and in the local region.

The Innovation Hub and Downtown District
BioLabs, a premier co-working space for life science startups, announced that it will be the first business partner to
collaborate with the University and Town through the new innovation district. As an anchor to the
district, Carolina’s innovation hub is scheduled to open in spring 2023.

continue reading

Link to download full report: InnovateCarolina_AnnualReport_2022

UNC Resources Innovate Carolina